Agoracom Blog Home

Archive for the ‘Featured’ Category

$APPB Applied BioSciences Expands TherPet Line with Equine Care Line

Posted by AGORACOM at 10:55 AM on Wednesday, May 9th, 2018

  • TherPet has entered the equine health space
  • Launched hemp-derived cannabidiol (“CBD”) formulated specifically for a horse’s health and wellness
  • Horses also have an endocannabinoid system comprised of cannabinoid receptors that help regulate a wide variety of bodily functions ranging from pain relief to mood.

 

LOS ANGELES, CA / May 9, 2018 / Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company’s wholly-owned animal health subsidiary TherPet has entered the equine health space with the launch of a new full-spectrum hemp-derived cannabidiol (“CBD”) supplement formulated specifically for a horse’s health and wellness.

TherPet’s Equine Care CBD line is a natural supplement designed to play a key role in keeping horses, healthy, looking good and performing their best. Our Equine Care CBD products support healthy skin, joints and immune system as well as to ease the discomfort of fatigued muscles, stiff joints and arthritis pain.

Like humans, horses also have an endocannabinoid system comprised of cannabinoid receptors that help regulate a wide variety of bodily functions ranging from pain relief to mood.

“Regularly supplementing a horse’s endocannabinoid system with full-spectrum CBD enables horses to better control inflammatory responses naturally,” noted JJ Southard, Vice President of Products at Applied BioSciences Corp. “Despite millions of spectators tuning in to watch twenty of the fastest thoroughbred horses compete in the Kentucky Derby this past weekend, very few of them realize or consider the race-induced inflammation and injuries that take place during such an event.”

David Horohov, Ph.D., William Robert Mills Chair at the University of Kentucky’s Gluck Equine Research Center, believes that horses as a breed are not necessarily becoming more fragile, but rather more susceptible to injury due to breeding strategies, training methods, and increased drug use. The Company hopes to reverse this trend by making Therpet’s new treatment options available immediately for veterinarians, trainers, and equestrians.

Therpet’s Equine Care tincture is available in a 4800 mg concentration which is packaged in a 4 fl. Oz. (120ml) bottle. The tincture is a naturally formulated Apple flavor, made with lab tested, CO2 extracted, pure full-spectrum CBD oil sourced from pesticide-free, Colorado grown hemp and specially formulated to be the highest bioavailability CBD products in the marketplace.

TherPet products are USDA NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC-free. The products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanical, herbal and essential oils to further optimize bioavailability.

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com

Brands:

www.remedishop.com
www.therpet.com

Follow us:

Facebook @remedicbd & @therpetcbd
Instagram @remedicbd & @therpet
Twitter @remedishop & @therpet

FEATURE: Glacier Lake Resources Silver Vista Assays Pending $JAX.ca $AMI.ca $GTT.ca $HBM.ca

Posted by AGORACOM at 8:39 AM on Tuesday, May 8th, 2018

Developing Silver Vista Project into Bulk Tonnage Silver & Copper

  • Completed 2018 Phase 1 drill program
  • Seven holes, totalling 1,273 metres drilled
  • Silver Vista Project, a sediment hosted Cu & Ag deposit with potential to host bulk mineralization
  • Sediment-hosted copper deposits include some of the richest and larges deposits in the world
  • Soil Geo-Chem survey defined anomaly 2.0KM by 1.5KM named the “MR prospect area”
  • Drilling focused at “MR”
  • Drill program results expected within 2Q/2018

 

Glacier Lake Power Point

Namaste $N.ca $NXTTF Signs Exclusive Drop-Shipping Agreement With Ample Organics Enabling Ample’s Licensed Producer Customers to Sell Vaporizers and Accessories $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:49 AM on Monday, May 7th, 2018

  • Signed an exclusive drop-shipping supply agreement with Ample Organics Inc.
  • Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis
  • Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system

VANCOUVER, British Columbia, May 07, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed an exclusive drop-shipping supply agreement (the “Agreement”) with Ample Organics Inc. (“Ample Organics”). Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis (“LPs”). Under the terms of the Agreement, Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system. This will allow each of Ample Organics’ LP customers to have instant access to a large variety of devices and accessories available for purchase during checkout. The Agreement will provide added value for Ample Organics customers by offering their patients industry-leading products. Namaste is proud to have this unique opportunity in partnering with Canada’s most innovative seed-to-sale software company and this Agreement clearly demonstrates Namaste’s continued focus on achieving technological development for the cannabis industry.

Key Terms of the Agreement

  • Namaste will supply Ample Organics customers with access to the Company’s full range of vaporizers and accessories through an API integration, as the exclusive drop-shipping supplier to Ample Organics.
  • Namaste will have first right of refusal to supply new products as requested by Ample Organics, or its customers, for drop-shipping through the API integration.
  • In the event that Namaste decides not to carry a new product or cannot source such product within 30 days, Ample Organics will be granted the right to offer the new product using drop-shipping through a 3rd party supplier.
  • Each order will be submitted electronically via API integration that will also provide live access to tracking information, inventory and shipping data.
  • Namaste will be responsible, at its cost for all product support, returns and warranty claims.
  • Unless Namaste advises otherwise, solely due to pricing restrictions from the product manufacturers, Ample Organics and its customers shall agree to set the prices for the Products at a Minimum Advertised Price (MAP), to be specified by Namaste for each product.

Namaste’s partnership with Ample Organics represents a unique opportunity to provide virtually hundreds of thousands of medical cannabis patients with access to a variety of high-quality vaporizers, which research has shown is a far superior and healthier way to consume medical cannabis. This agreement further demonstrates Namaste’s commitment to the medical cannabis patients of Canada, and in ensuring that they have easy and affordable access to the best cannabis hardware products on the market.

The Agreement represents an important step for Namaste and is accretive in nature, as it will provide immediate, low-overhead revenue for both Namaste and Ample Organics. The Company will now focus its efforts on completing the integration with Ample Organics as soon as possible and will continue to explore further opportunities that have the potential to bring value to Namaste, its partners, and the entire cannabis market.

Management Commentary

John X. Prentice, President and CEO of Ample Organics comments; “This partnership represents a substantial value-add for Ample Organics’ clients and their patient customers. It will simplify inventory management and fulfillment for LPs, while ensuring that medical cannabis patients across the country have access to a substantial catalogue of vaporizers and cannabis accessories at great prices. We are excited to continue the development of our relationship with Namaste and look forward to advancing the industry in new and innovative ways together.”

Sean Dollinger, President and CEO of Namaste comments; “We are very proud to be partnered with Ample Organics on this project. It’s been very rewarding to collaborate with the management team, on what we believe is an important initiative for all those involved, most importantly of which are the medical cannabis patients of Canada. We are incredibly excited to be associated with Ample Organics and to have the opportunity to provide healthier, more affordable options for medical patients to consume cannabis. Our commitment to developing a platform with easily accessible products and services for the cannabis industry is what inspired the opportunity to work with Ample Organics. We’re looking forward to completing the integration and to further enhancing the patient experience.”

About Ample

Ample Organics is Canada’s leading cannabis business solution, adopted by 75% of the nation’s Licensed Producers. To date, the Ample Organics platform has processed more than 880,000 orders and 16,000,000 grams of cannabis. Ample Organics makes compliance easy by tracking individual plants from seed to consumer and reporting every detail of the growth, production, and sales processes. With Ample Organics, data is collected at the most granular levels, offering insights that can drive business decisions and help to protect public safety. Beyond seed to sale, Ample Organics’ extended suite of products creates a complete ecosystem for cannabis businesses. From easy patient registration to cannabis-exclusive payment solutions, Ample Organics continues to evolve and release new products to provide reliable and compliant solutions for the cannabis industry.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors,

Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

For more information about Ample Organics, please visit ampleorganics.com or contact:
Peter Slater
VP, Corporate Development
Direct: +1 (416) 262-4175
Email: [email protected]

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Namaste $N.ca Acquires #Findify, a Leading A.I. and Machine Learning Company, to Increase Conversion Rates, Average Order Value, Retention and Referrals $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 11:06 AM on Wednesday, May 2nd, 2018

Nlogo

  • Company executed a definitive agreement to acquire all of the issued and outstanding shares of Findify AB
  • purchase price of US $12,000,000 in a combination of cash and common shares of the Company
  • Findify is a global leader in A.I. powered e-commerce personalization, delivering solutions such as personalized search, recommendations, and advanced data analytics

VANCOUVER, British Columbia, May 02, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that on May 1, 2018 the Company executed a definitive agreement to acquire (the “Acquisition”) all of the issued and outstanding shares of Findify AB (a Swedish corporation, “Findify”), for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company. Findify is a global leader in A.I. powered e-commerce personalization, delivering solutions such as personalized search, recommendations, and advanced data analytics. Among its customers are Nine West, PLV Shoes, and Rocketdog.

Management expects the integration of Findify’s proprietary technology to increase monetization and propel revenue growth in both cannabis and hardware sales. In addition to anticipated growth in Namaste’s core business, the Company will allocate resources to expand on Findify’s existing platform and expects this to result in increased EBITDA by the end of 2019. Namaste also anticipates accelerating patient growth through its wholly owned subsidiary and Canada’s first fully-compliant online patient portal, NamasteMD Inc. (“NamasteMD” or “NamasteMD.com”). By implementing Findify’s technology in applications of patient acquisition, conversion rates, order value and customer retention, the Company expects to reach 50,000 medical cannabis patients by the end of 2018 and up to 100,000 by the end of 2019.

Findify’s platform which is used by leading e-commerce websites, including Namaste, uses proprietary real-time machine learning algorithms to build unique user profiles, and deliver a personalized experience for each user. The platform continuously learns from user behavior to automatically improve search results, recommendations, and product landing pages, displaying the most relevant products at any given time. It identifies product trends and, in combination with an analysis of unique customer behavior, ranks products in a way to optimize revenue, conversion rates and average order value. Based on the Bank of Canada’s exchange rate on May 1, 2018, Findify’s annual 2017 revenue was $503,170 and its first quarter 2018 revenue was $198,211.

Key terms of the Acquisition:

  • Namaste will acquire all issued and outstanding shares of Findify in exchange for:
    • US $2,000,000 in cash to be paid upon the closing date of the transaction.
    • US $10,000,000 to be paid in common shares of Namaste at a mutually agreed price of C$1.80 per common share.

Key designated employees of Findify will be remaining with the company after the completion of the acquisition.

The acquisition of Findify brings an incredible amount of value to the Company in applications related to the online retail of medical cannabis. Namaste recognizes this as a unique opportunity to offer medical cannabis patients an even more personalized experience. The acquisition of Findify will reinforce Namaste’s goal of becoming the global leader in cannabis technology solutions by further expanding its innovative e-commerce platform and enhancing the user experience for cannabis patients globally.

In addition, the acquisition of Findify creates a new revenue stream for the Company in the field of artificial intelligence and data analytics. Namaste will continue to operate and expand on Findify’s existing platform and client portfolio.  Namaste anticipates rapid expansion of its technology licensing business.

Management Commentary

Meni Morim, Founder and CEO of Findify comments: “The Findify team is very excited to join the Namaste family, and take part in revolutionizing the online cannabis domain. The team brings years of experience, having built a unique machine learning platform that leverages user behavior, to deliver a personalized e-commerce experience across touchpoints, with a focus on search & discovery. We believe that Namaste’s strong positioning in the market will enable us to take advantage of this technology in the best possible way, and deliver immediate value to customers and shareholders – by buildings the world’s first fully integrated A.I. platform for cannabis.

Having built a relationship with Namaste as a client over the past two years, we found that we share many of the same core values, work ethic, and passion for building products that people love. We’re confident that the merging of our teams will enable us to continue innovating in this fast-paced, growing industry.”

Laurens Feenstra, Director of Namaste, an A.I. expert, and Product Manager for Google Waymo comments: “I am super excited for the talented team of Findify to join Namaste! Their leading machine learning models have already made Namaste much better at recommending the right products to our customers. And, even more importantly, we are thrilled to apply their deep A.I. expertise to cannabis. There are approximately 800 identified strains of cannabis each with hundreds of active ingredients, meaning each plant works differently for each person. Understanding which plant works for whom will be key in helping cannabis benefit everyone.”

Sean Dollinger, President and CEO of Namaste comments: “We’re very pleased to announce the acquisition of Findify. This is a very exciting opportunity for Namaste to forge new ground in the cannabis industry by introducing what we believe to be the most innovative technology for on-site personalization. Moving forward we believe global cannabis patients will demand a more customized online experience, as products and services in the cannabis industry continue to grow exponentially. Having worked with Findify as a client, we have witnessed excellent results through the implementation of their technology and believe strongly in the quality of their management team. Based on the success we have seen in the utilization of similar technology in other industries, we are extremely excited and optimistic to become the first company to introduce this incredible technology into the cannabis market and further enhance the online experience for cannabis patients.

Our vision for the Company in becoming a global leader in medical cannabis technology is evident from the addition of our new board members coming from Google and SpaceX, industry leaders in the areas of machine learning and A.I. that chose to join Namaste’s team. Furthermore, this acquisition represents a major milestone for Namaste in solidifying itself as one of the most innovative technology companies in the cannabis industry.”

About Findify AB

Findify is a leader in e-commerce machine learning applications, with over 1200 customers in more than 60 countries around the world. Findify has developed a unique machine learning core, that leverages user behaviour, to personalize online experiences in real-time. Findify’s machine learning technology has been proven to deliver up to 27% uplift in conversion rate, and up to 30% uplift in revenue per user.

Findify is an official Shopify Plus Technology Partner, recognized as a “Best-In-Class Solution” for modern, rapidly growing e-Commerce businesses.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:
namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

$GGX.ca GGX Gold Extends the Gold Bearing COD Vein an Additional 65 Meters to the South — Greenwood BC

Posted by AGORACOM at 9:29 AM on Wednesday, May 2nd, 2018

  • Completed holes 25 through 30 on the COD Vein, located in the Gold Drop Southwest Zone
  • DD-COD18-30 extended the COD vein 65 meters to the south, intersecting a 2.2 meter mineralized quartz vein with visible tellurides and visible gold.
  • The company is continuing with its summer drill program utilizing two drill rigs

 

Vancouver, British Columbia (FSCwire)GGX Gold Corp. (TSX.V: GGX) (OTCQB: GGXXF), (the “Company” or “GGX”) is pleased to announce the completion drill holes 25 through 30 on the COD Vein, located in the Gold Drop Southwest Zone. Thirty holes have been completed to date during the current 2018 diamond drill program testing the COD Vein, totaling 2,020 meters (6,627 feet).

 

To view the graphic in its original size, please click here

 

To view the graphic in its original size, please click here

The latest series of diamond drill holes were drilled from a pad located 40 meters south of the 2017 COD trenches. These holes targeted an area of historical cross trenches that never reached bedrock. The highlight of the latest series of holes is DD-COD18-30 that extended the COD vein 65 meters to the south. The hole intersected a 2.2 meter mineralized quartz vein with visible tellurides and visible gold.

 

To view the graphic in its original size, please click here

Listed below are the highlights from the latest series of COD diamond drill holes. All reported widths are core length.

DDCOD18-26 – intersected a 11.25 m mineralized zone including 6.38 m of quartz veining.

DDCOD18-29 – intersected a 3.94 m mineralized zone including 1.6 m of quartz vein intercept.

DDCOD18-30 – intersected a 3.51 m mineralized zone including a 2.2 m quartz vein intercept.

The core is currently being split and securely packaged for shipment to ALS laboratories in Vancouver, BC. There the core will be analyzed for gold by Fire Assay and for 48 multi element Four Acid and ICP-MS. Quality control (QC) samples are being inserted at regular intervals.

The company is continuing with its summer drill program utilizing two drill rigs, one drill is on the newly discovered Everest Vein located approximently 100 Meters west of the COD and 600 Meters south of the COD trench. The second Drill rig is continuing to extend the Gold bearing COD vein both north and south.

Further updates on these programs will be provided shortly and a steady flow of assays results are expected to begin at the end of May and continue over the seasons program.

 

To view the graphic in its original size, please click here

David Martin, P.Geo., a Qualified Person as defined by NI 43-101 and consultant for GGX, is responsible for the technical information contained in this News Release.

To view the Original News release with pictures please go to the website or contact the company.

On Behalf of the Board of Directors,

Barry Brown,

Director

604-488-3900

[email protected]

Investor Relations:

Mr. Jack Singh, 604-488-3900   [email protected]

“ We don’t have to do this, we get to do this ”

The Crew

 

To view the graphic in its original size, please click here

PyroGenesis Announces 2017 Results: Revenues Increase 38%; Gross Margins Increase to 44%; Gross Profit Increases 258%; EBITDA (Mod.) Improves 22% Year Over Year; Current Backlog $7.2MM; Pipeline exceeds $20MM

Posted by AGORACOM-JC at 9:39 AM on Tuesday, May 1st, 2018

Pyr header 1

2017 was a year in which PyroGenesis posted:

  • An increase of 38% in Revenues to $7,192,861 year over year;
  • A 258% increase in Gross Profit to $3,126,967 compared to a loss of ($1,980,336) in 2016;
  • An increase in Gross margins (Before amortization of intangible assets and write-offs of inventories and costs and profits in excess of billings on uncompleted contracts) to 43.5% (2016: 41.6%);
  • An increase in Gross margins (After amortization of intangible assets and write-offs of inventories and costs and profits in excess of billings on uncompleted contracts) to 43.5% (2016: 14.8%);
  • 22% decrease in Modified EBITDA loss to ($1,445,784) for fiscal 2017;
  • A backlog of $7.2MM at December 31, 2017;
  • Pipeline exceeds $20MM (Pipeline is considered to be negotiations with either existing clients who wish to re-order, or new clients that have paid for demonstrations after receiving a quote).

MONTREAL, April 30, 2018 – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V:PYR) (OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, is pleased to announce today its financial and operational results for the fourth quarter and the fiscal year ended December 31, 2017.

“2017 was a year in which all key indicators of operational performance posted significant gains, year over year, and once again the Company is well positioned for the coming year,” said P. Peter Pascali, President and CEO of PyroGenesis. “2016 was a pivotal year for PyroGenesis as the Company decided to re-enter the market for metal powder production (this time for additive manufacturing), and leverage off of both its extensive Plasma expertise and the fact that it invented Plasma Atomization for this space.  2017 became the year in which the Company went from relative obscurity within the additive manufacturing industry to being nominated for “Materials Company of the Year” at the 3D Printing Industry Awards 2018.  2017 also saw the commercial acceptance of its patented DROSRITE™ System with the acceptance of its first commercial sale and a subsequent re-order by the same client.   As reviewed in a press release dated February 1st, 2018, we now have visibility on an additional 6-10 DROSRITE™ systems to be delivered in 2018 and there is a high probability that the Company will be profitable in 2018 from the addition of DROSRITE™ system sales to our backlog. All this to say that 2017 seems to have set the stage for a profitable 2018.”

Highlights

2017 was a year in which PyroGenesis posted:

  • An increase of 38% in Revenues to $7,192,861 year over year;
  • A 258% increase in Gross Profit to $3,126,967 compared to a loss of ($1,980,336) in 2016;
  • An increase in Gross margins (Before amortization of intangible assets and write-offs of inventories and costs and profits in excess of billings on uncompleted contracts) to 43.5% (2016: 41.6%);
  • An increase in Gross margins (After amortization of intangible assets and write-offs of inventories and costs and profits in excess of billings on uncompleted contracts) to 43.5% (2016: 14.8%);
  • 22% decrease in Modified EBITDA loss to ($1,445,784) for fiscal 2017;
  • A backlog of $7.2MM at December 31, 2017;
  • Pipeline exceeds $20MM (Pipeline is considered to be negotiations with either existing clients who wish to re-order, or new clients that have paid for demonstrations after receiving a quote).

Outlook

2017 was a year in which all key indicators of operational performance posted significant gains and positioned the Company for profitability in the future.  Building upon the successes of 2016, which saw the establishment of healthy gross margins, in excess of 40% continue and improve throughout 2017, as the Company put in place the infrastructure and personnel to ensure that these margins, not only continue into the foreseeable future, but improve once powder production is in full commercialization.

The following is a non-exhaustive review of PyroGenesis’ main commercial activities:

A)  Powder Production:

2017 became the year in which the Company went from relative obscurity within the additive manufacturing industry, to being nominated “Materials Company of the Year” at the 3D Printing Industry Awards 2018.

Not only, during this period,  did the Company successfully assemble and commission its first metal powder production system, but also (i) successfully delivered orders for Titanium and Inconel powders, all while still in the ramp up phase, (ii) generated new, game changing, IP which provides for more control over particle size distribution, with little to no waste, while increasing powder production even further, and (iii) entered into several NDA’s with significant players in the industry (end users, printer manufacturers, and distributors) all with a view of providing sample orders, repeat orders, long term orders, contract R&D, and/or strategic partnerships for long term powder supply contracts, some with a view to a possible acquisition.  Given the level of activity, and the prospect of significant orders in the near term, management decided to order the long lead items for two powder production systems, both of which should be fully operational by the end of July 2018. These new powder production units will incorporate some of the cutting-edge IP that has recently been developed and/or is in development. We expect these units will cost significantly less to manufacture, generate higher production rates, and provide greater control over particle size distributions.

Of note, although the Company’s strategic plan has always been based on its existing IP, know-how, and system (the economics of which remain true to this day), management has decided to leverage off of its significant advantage in plasma technology and dedicate certain limited assets to increasing its IP base with the goal of further significantly reducing capital and operating costs of the powder production system while at the same time improving production rates even further.  PyroGenesis is confident that these goals once achieved will significantly impact our build out strategy for the better.

The Company expects that one of the next significant milestones is to be formally placed on a powder user’s approved supplier list.  This requires significant time and money on the part of the user and would be the first formal step to a powder production contract. Although we cannot predict the time frame in which this might happen, we can confirm that we have not been rejected during any powder qualification process leading to this ultimate goal.

B)  DROSRITE™:

As the Company positioned itself, during 2017, to become a significant powder producer to the Additive Manufacturing Industry, it also successfully positioned its DROSRITETM Furnace System to become a fully commercial product line in and of its own right.

2017 saw the commercial acceptance of PyroGenesis’ patented DROSRITE™ System with, not only an acceptance of its first commercial sale, but a subsequent re-order by the same client at a higher price.

During this time, a successful demonstration of the DROSRITE™ System in the Middle East has resulted in significant interest from that region while the Company’s demonstration unit is already fully booked in India, to September, with paid-for-demonstrations. This flurry of activity and interest for the DROSRITE™ System resulted in the Company hiring a full-time business development manager to market the DROSRITE™ System, and who’s role is exclusively to secure DROSRITE™ system sales. PyroGenesis is aggressively targeting both primary aluminum smelters in Asia and the Middle East where the market is estimated to be in excess of 1 million tonnes of dross1, as well as tertiary casting producers worldwide. These two markets alone represent a potential market for DROSRITE™ systems numbering in the hundreds of units.

1 http://www.world-aluminium.org/statistics/primary-aluminium-production/

As of this writing, PyroGenesis

  1. is currently discussing the purchase of an additional two (2) systems with an existing client;
  2. has demonstrated the system in the Middle East and are expected to close on the equivalent of three (3) systems over the next few months;
  3. has a demonstration system in India on contract for paid-for-demonstrations, which if successful could result in 1-4 additional orders;

Plus,

  1. as noted, this demonstration system is fully booked until September 2018.

Due to this high demand for on-site paid-for demonstrations, the Company is in the process of constructing a second DROSRITE™ demonstration system which is expected to be available for demonstrations in Q3 2018.  There is a high probability that PyroGenesis will be profitable in 2018 from DROSRITE™ system sales when combined with existing backlog.

C)  US Military:

Originally it was thought that just one new US Aircraft Carrier would be ordered in 2018, with an estimated value of approximately $6MM, but now it seems that the interest is for two, for an estimated value of between $10-12MM.

The chemical warfare destruction unit, that PyroGenesis developed for a consortium involving various groups within the US military, and was in the process of being tested, continues to have its schedule delayed to accommodate other unrelated testing needs by the group. This testing timeline is out of the Company’s control.

Revenues from military contracts in 2017 were over $4,300,000, mainly related to providing technical support, training services and sale of spare parts.  Over the past three years, revenues from military contracts have typically represented more than $2,000,000 per year of PyroGenesis’ revenues.  As the PAWDS technology becomes fully operational on US Navy ships, management expects the level of recurring revenues from the sale of parts and services to increase over the next 2 to 5 years.

D)  HPQ:

On August 2, 2016, PyroGenesis announced that it had signed contracts totalling $8,260,000 with HPQ Silicon Resources Inc., formally Uragold Bay Resources Inc. (“HPQ”) for the sale of IP and to provide a pilot system to produce silicon metal directly from quartz. Of particular note, if successful, PyroGenesis benefits from a 10% royalty on all revenues derived from the use of this system by HPQ, subject to annual minimums.

Management remains focused on reducing PyroGenesis’ dependency on long-cycle projects by developing a strategic portfolio of volume driven, high margin/low risk products that resolve specific problems within niche markets and doing so by introducing these plasma-based technologies to industries that have yet to consider such solutions.

Management is also actively targeting recurring revenue opportunities that will generate a growing, and profitable, regular cash flow to the Company.

PyroGenesis has one of the largest concentrations of plasma expertise in the world, with over 250 years of accumulated technical experience and supporting patents, combined with unique relationships with major Universities performing cutting edge plasma research and development, positions the Company well to execute its strategies.

Management’s focus will continue to be to generate an improved mix of short and long-term projects that will, in turn, facilitate operational and financial planning. Repeat orders for the same, or similar, products will further result in the standardization of manufacturing processes which will lead to improved gross margins.

All indications are that 2018 should be a profitable year for the Company given that business lines, other than non-additive manufacturing, continue to contribute significantly to Pyrogenesis’ revenues.  Management expects that the Corporation’s non-additive manufacturing business lines will generate enough revenues, on their own in 2018, to make PyroGenesis profitable overall.

Financial Summary

Revenue

PyroGenesis recorded revenue of $7,192,861 in the year of 2017, representing an increase of 38% compared with $5,222,133 recorded in the year of 2016.

Revenues recorded in fiscal 2017 were generated primarily from:

  1. the development of a vacuum arc reducing process to convert Silica into high purity Silicon metal,
  2. the manufacture and further field testing of Tactical PACWADS, the first mobile plasma system for destruction of chemical warfare agents under contract with an international military consortium,
  3. the demonstration of the viability of PyroGenesis’ existing plasma chemical warfare agent destruction platform with locally available materials, for the complete eradication of chemical warfare agents without creating hazardous by-products,
  4. support services related to PAWDS-Marine systems supplied to the US Navy.

Cost of Sales and Services and Gross Margin

Cost of sales and services before amortization of intangible assets was $4,065,894 in 2017, representing an increase of 33% compared with $3,051,356 in 2016.

In 2017 employee compensation, subcontracting costs, direct materials and manufacturing overhead increased to $4,436,508 (2016 – $3,277,813) as a result of increased volumes during the year.  The cost of sales and services for 2017 and 2016 are in line with management’s expectations. The type of contracts being executed, and the nature of the project activity has a significant impact on both the overall level of cost of sales and services reported in a period, as well as the composition of the cost of sales and services, as the mix between labour, materials and subcontracts may be significantly different. The cost of sales and services for 2017 and 2016 are in line with management’s expectations

Investment tax credits recorded against cost of sales are primarily related to client funded projects that qualify for tax credits from the provincial government of Quebec. Qualifying tax credits increased to $367,342 in 2017, compared with $249,550 in 2016. This represents an increase of 47% year-over-year. The increase is primarily due to a higher amount of these costs being eligible for tax credits.

The gross margin before amortization of intangible assets for 2017 was $3,126,967 or 43.5% of revenue compare to a gross margin of $2,170,777 or 41.6% of revenue for 2016 before amortization of intangible assets and write-offs of inventories and costs and profits in excess of billings on uncompleted contracts. The inventory write-off in 2016 was comprised of the Transportable Waste to Energy system ($147,774) and the CFC destruction system ($846,241). The write-off of costs and profits in excess of billings on uncompleted contracts ($1,760,423) was related to the Company no longer expecting to recover the full amounts owed from a customer for a contract.

The amortization of intangible assets of $Nil in 2017 and $1,396,675 for 2016 relates to the licenses and know-how purchased in 2011 from a company under common control. Of note, this expense is a non-cash item and the underlying asset was fully amortized by December 31, 2016.

Selling, General and Administrative Expenses

Included within Selling, General and Administrative expenses (“SG&A”) are costs associated with corporate administration, business development, project proposals, operations administration, investor relations and employee training.

SG&A expenses for 2017 excluding the costs associated with share-based compensation (a non-cash item in which options vest principally over a two-year period), were $4,394,837, representing an increase of 10% compared with $3,990,837 reported for 2016.

The increase in SG&A expenses in 2017 over the same period in 2016 is mainly attributable to the net effect of:

  • an increase of 11% in employee compensation due primarily to additional headcount,
  • a decrease of 11% for professional fees, primarily due to a decrease in investor relations expense and patent expenses,
  • an increase of 27% in office and general expenses, due to an increase in computers and internet expenses,
  • travel costs increased by 29%, due to an increase in travel abroad,
  • depreciation on property and equipment decreased by 12% due to a lower amount of property and equipment being depreciated. In 2017, the Company had $1,879,455 of assets under development, which will begin to be depreciated when these assets are available or ready for use (expected in 2018),
  • government grants decreased by 11% due to a decreased level of activities supported by such grants and,
  • other expenses increased by 61%, primarily due to an increase in promotion and advertising expenses, an increase in marketing expenses, and an increase in insurance expense.

Separately, share based payments increased by 107% in 2017 over the same period in 2016 as a result of the vesting structure of the stock option plan including the stock options granted on November 3, 2017.

Net Comprehensive Loss

The net comprehensive loss for 2017 of $6,174,303 compared to a loss of $6,952,219, in 2016, represents a decrease of 11% year-over-year.

The decrease of $777,916 in the comprehensive loss in 2017 is primarily attributable to the factors described above, which have been summarized as follows:

  1. an increase in product and service related revenue of $1,970,728 arising in 2017,
  2. an increase in cost of sales and services totaling $1,014,538, primarily due to the concentration of engineering on material purchases, and due to the increase in product and service revenue,
  3. a decrease in amortization of intangible assets of $1,396,675,
  4. a decrease in impairment loss in 2017 of $2,754,438 recorded in 2016 for a write-off of inventories and costs and profits in excess of billings on uncompleted contracts,
  5. an increase in SG&A expenses of $796,988 arising in 2017 primarily due to an increase in employee compensation and office and general expenses,
  6. an increase in R&D expenses of $197,672 primarily due to the increase in development expenditures relating to the asset under construction in 2017,
  7. an increase in the settlement of the IP debt balance of $3,215,643,
  8. an increase in net finance costs of $119,084 in 2017 primarily due to an increase in the adjustment in fair value of investments.

EBITDA, Adjusted and Modified

The EBITDA loss in 2017 was $5,558,640 compared with an EBITDA loss of $4,935,997 for 2016, representing an increase of 13% year-over-year. The decrease in the EBITDA loss in 2017 compared with 2016 includes amounts written-off of $2,754,438 in 2016.

Adjusted EBITDA loss in 2017 was $1,583,984 compared with an Adjusted EBITDA loss of $1,815,534 for 2016. The decrease of $231,550 in the Adjusted EBITDA loss in 2017 is attributable to the decreased comprehensive loss of $777,916, a decrease of $15,468 in depreciation on property and equipment, a decrease of $1,396,675 in amortization of intangible assets, an increase in finance charges of $11,584, an increase in cost of other non-cash items, specifically share-based payments of $392,988, an increase in a settlement of a claim related to the long-term debt of $3,215,643 a decrease in write-off of inventories of $994,015 and a decrease in write-off of costs and profits in excess of billings on uncompleted contracts of $1,760,423.

The Modified EBITDA loss in 2017 was $1,445,784 compared with a Modified EBITDA loss of $1,846,234 for 2016, representing a decrease of 22%. The decrease in the Modified EBITDA loss in 2017 is attributable to the decrease as mentioned above in the Adjusted EBITDA and a decrease in change of fair value of investments of $168,900.

Liquidity and Capital Resources

The Company has incurred, in the last several years, operating losses and negative cash flows from operations, resulting in an accumulated deficit of $43,200,708 and a negative working capital of $9,403,370 as at December 31, 2017 (December 31, 2016 – $37,026,405 and $2,079,353 respectively). Furthermore, as at December 31, 2017, the Company’s current liabilities and expected level of expenses for the next twelve months exceed cash on hand of $622,846 (December 31, 2016 – $385,257). The Company has relied upon external financings to fund its operations in the past, primarily through the issuance of equity, debt, and convertible debentures, as well as from investment tax credits.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2008 certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact: Rodayna Kafal, VP, Investor Relations and Strategic Business Development, Phone: (514) 937-0002, E-mail: [email protected] 

$AAO.ca Augusta Announces Results for the First Quarter of 2018 and Year Ending December 31st 2017 and Corporate Update

Posted by AGORACOM at 8:23 AM on Tuesday, May 1st, 2018

 

  • Three months ending March 31, 2018, the Corporation had revenues of $1,720,000 as compared to $879,000 during the three months ending March 31, 2017.
  • Total profit from operations for the three months ending March 31, 2018 was $31,000
  • The operating expenses in the three months ending March 31, 2018 was less at $244,000 compared to $277,000 for the same period in 2017.

Toronto, Ontario–(Newsfile Corp. – May 1, 2018) – Augusta Industries Inc. (TSXV: AAO) (the “Corporation”) is pleased to announce that it has released its financial results for the year ended December 31, 2017 and for three months ended March 31, 2018.

Summary for Three Months Ended March 31, 2018

For the three months ending March 31, 2018, the Corporation had revenues of $1,720,000 as compared to $879,000 during the three months ending March 31, 2017.

Total profit from operations for the three months ending March 31, 2018 was $31,000 or a net profit of $0.00 per share compared to a loss of $77,000 or $0.00 per share for the three months ending March 31, 2017. Gross margins for the three months ending March 31, 2018 was 16% compared to 23% for the three months ending March 31, 2017 due to the change in mix between Macron and FOX-TEK sales during the period. The operating expenses in the three months ending March 31, 2018 was less at $244,000 compared to $277,000 for the same period in 2017. Stock based compensation during the three months ending March 31, 2018 was $31,000 compared to $101,000 during the three months ending March 31, 2017.

Summary for Year Ended December 31, 2017

For the year ended December 31, 2017, the Corporation had revenues of $2,556,000 compared to $4,596,000 during the year ended December 31, 2016.

Total loss from operations for the year ended December 31, 2017 was $666,000 or a net loss of $0.00 per share compared to a profit of $7,000 or $0.00 per share for the year ended December 31, 2016. Gross margins for the year ended December 31, 2017 was 21% similar to 22% for the year ended December 31, 2016. The operating expenses in the year ended December 31, 2017 was slightly higher at $1,209,000 compared to $1,019,000 for the same period in 2016. Stock based compensation during the year ended December 31, 2017 was $250,000 while there were no such expenses during the year ended December 31, 2016.

The financial statements, notes to the financial statements and Management’s Discussion and Analysis for the year ended December 31, 2017 and for three months ended March 31, 2018 are available on SEDAR at www.sedar.com.

Corporate Update – Business Development

Blockchain Technology

The Corporation has created a wholly owned subsidiary, Paragon Blockchain Inc. (“Paragon”) to commence the process of implementing blockchain technology. Paragon has entered into a memorandum of understanding with an undisclosed blockchain company (the “UBC”) to advise and develop a new set of blockchain applications for the Corporation. The UBC will act as technical advisor and initiate the process of developing a new set of blockchain applications that will integrate, amongst other things, artificial intelligence (“A.I.”) for the purpose of sorting critical procurement opportunities within US government agencies for Marcon International Inc. (“Marcon”), Fox-Tek Canada Inc. (“Fox-Tek”).

Blockchain technology has the potential to unlock substantial new opportunities capable of impacting the business of Marcon. Specifically, Marcon seeks to create an eco-system in the supply chain management of clients to change the dynamics of the scoping and bidding process by providing vendors and subcontractors with A.I. data mining tools to proactively drive the process.

Blockchain technology is of critical importance to Fox-Tek as well particularly the expansion of its’ non-intrusive technology in the oil and gas industry, whose clients include many of the biggest companies in the world. Fox-Tek believes a common system of record connecting data collected for events is of paramount importance to clients. The Corporation will create a platform that will allow for the analysis of data that incorporates an auditing system built for regulatory and quality assurance oversight. The platform will implement a distributed blockchain ledger using smart contracts. These smart contracts provide customization of blockchain data.

Fox-Tek Segment

Fox-Tek continues to support its independent sales agents and distributors primarily outside of North America with the intent of utilizing their local contacts and established relationships within the oil and gas industry to expedite the distribution of Fox-Tek’s products in the local jurisdictions.

After a very successful first introductory trip to India, Fox-Tek has submitted a number of technical proposals and bids on a number of different projects based on the Corporation’s various technologies. One of the more interested oil companies has requested a bid for 2 large EFM systems to be placed on vessels within a refinery. The client has provided a sample plate for testing purposes that would lead to a custom design for that specific material. The Corporation is also working on introducing our leak detection technology for long distance applications in India.

The Corporation has initiated talks with the Ontario Centres of Excellence (“OCE”) to supplement a number of high quality personnel within the OCE. This includes having a Post Doctorate Fellow to come to the offices of the Corporation and provide a full assessment on the company’s data analysis techniques and to look at ways to better manage our large database of data.

Through OCE, Fox-Tek, along with the McMaster University’s Centre of Opportunity, will be developing an innovative constant current source. This will be used across all of the Corporation’s EFM products, providing its existing and new clients with a better quality of analysis with the use of a high precision constant current source. A full prototype demonstrator has been completed.

The Corporation has been working to fulfill its obligations toward the engineering and field services to meet the requirements of the contract announced on July 10, 2017 with one of the Corporation’s largest and long standing clients in North America.

The Corporation is still working closely with the Trans Africa Pipeline project (“T.A.P.”) to provide non-intrusive sensing equipment which will verify the integrity of the pipeline composite at key locations. In addition to the non-intrusive sensing equipment, Fox-Tek will provide optical based sensing technology which would allow T.A.P. to monitor the right of way zones from possible third-party intrusions. The last update was that partial financing is completed and the site survey will be concluded for the Desalination Plant will be underway later in 2018.

The company is continuing with the qualification process with Petrobras to become a supplier of corrosion detection monitoring systems, optical strain/pressure/temperature sensors & leak detection technology.

The Corporation is working with FiBos on two separate applications to monitor pressure in injectors. These injectors are critical to the plant operations since failures could lead to slowdowns or shutdowns of operations. A proof of concept was successfully completed and we are current working Phase 2

Sales of EFM Corrosion Monitoring Systems

The Corporation has successfully completed 3 site surveys for one of its largest and long standing clients in North America and is negotiating a contract with the client to convert a competitor’s technology to Fox-Tek’s EFM technology.

The Corporation continues to work closely with engineering firms and major oil and gas companies in the Middle East, England, in addition to all the major Canadian companies. There have been increased interest in the Corporation’s products from a number of overseas markets including India and the UK. The Corporation entered into a contract in 2016 with a company in the U.K. for the supply of a custom built EFM system for a laboratory. This system was shipped out in the first quarter of 2017 and installed in the second quarter of 2017. The Corporation is confident this could lead to future orders for more portable and mobile systems that could be used for periodic monitoring for less critical applications.

The Corporation is also negotiating a contract for sale of another EFM unit to another of its clients.

DMAT Platform

The Corporation continues to enhance the DMAT platform (Data Management and Analysis Tool). Response from customers utilizing the DMAT service has been very positive. For DMAT, the revenue stream is guaranteed when a customer acquires the hardware. The Corporation has successfully negotiated new contracts with several clients, for engineering services and data analysis, for the 2017 fiscal year and beyond.

Leak Detection Technology

Fox-Tek’s leak detection technology has the potential of becoming a disrupting technology within the oil and gas sector due to its ability to detect minute amounts of volatile organic compounds present in hydrocarbon leaks. Due to the nature of the technology, it will likely have fewer false alerts unlike a number of competing technologies.

  1. The Corporation has received a contract for a system to detect oil on water in a drainage culvert.
  2. The Corporation has been invited to be part of an onsite technical review for the use of its technology to monitor leaks in a pipe, within a tank farm. A budgetary/technical proposal was provided to the client. The pipe is estimated to be about 500 meters long. A site survey will be conducted end of April followed by contract negotiations
  3. Fox-Tek has successfully completed a valuation of its leak detection technology by a large consortium consisting of a number of oil and gas companies.
  4. Fox-Tek is working closely with CANMET on the development of a new sensor technology (RFID corrosion sensor) to be used as a way to determine the damage of time on pipeline coatings. A letter of interest was submitted pursuant to a government initiative and the company has been selected to participate in phase 2 – LOI Technical Review.

The company has an additional 5 bids for a number of applications utilizing a number of its technologies (EFM, FBG and leak detection.)

Marcon Segment

Marcon provides procurement and support services to existing and new projects worldwide in the energy sector. Initially Marcon had focused on providing services in the energy sector but moved on to government contracts and government services. Marcon has two subsidiaries, Marcon USA and Marcon UK, to help enhance and support its logistic and sales operations. Over the years it has established a good reputation and has been a consistent performer for its clients in the government as well as the international oil and gas industry.

Marcon has built an impressive pipeline of quotes in 2018 along with increased bidding activity. Majority of the larger bids and quotes for Marcon are time consuming both in preparation of the bidding process and with the client and the end users. Marcon has successfully signed numerous deals year to date and will continue to do so and update the public through periodic press releases. Backlog sales in Marcon for the period ending March 31, 2018 were $819,000.

About the Corporation:

Through its wholly owned subsidiaries, Marcon, Fox-Tek and Paragon, the Corporation provides a variety of services and products to a number of clients.

Marcon is an industrial supply contractor servicing the energy sector and a number of US Government entities. Marcon’s principal business is the sale and distribution of industrial parts and equipment (Electrical, mechanical and Instrumentation.) In addition to departments and agencies of the U.S. Government, Marcon’s major clients include Saudi Arabia-Sabic Services (Refining and Petrochemical), Bahrain National Gas Co, Bahrain Petroleum, Qatar Petroleum, Qatar Gas, Qatar Petrochemical, Gulf of Suez Petroleum, Agiba Petroleum and Burullus Gas Co.

Fox Tek develops non-intrusive asset health monitoring sensor systems for the oil and gas market to help operators track the thinning of pipelines and refinery vessels due to corrosion/erosion, strain due to bending/buckling and process pressure and temperature. The Corporation’s FT fiber optic sensor and corrosion monitoring systems allow cost-effective, 24/7 remote monitoring capabilities to improve scheduled maintenance operations, avoid unnecessary shutdowns, and prevent accidents and leaks.

Blockchain technology has the potential to unlock substantial new opportunities capable of impacting the business of Marcon. Specifically, Marcon seeks to create an eco-system in the supply chain management of clients to change the dynamics of the scoping and bidding process by providing vendors and subcontractors with A.I. data mining tools to proactively drive the process. Blockchain technology is of critical importance to FOX-TEK as well particularly the expansion of its’ non-intrusive technology in the oil & gas industry, whose clients include many of the biggest companies in the world.

Corporation contact:

Allen Lone, President, CEO, Augusta Industries Inc.
Tel: (905) 275 -8111 Ext 226 email: [email protected]

The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and as neither approved nor disapproved the contents of this press release.

Namaste $N.ca $NXTTF Announces Record-Breaking Quarterly Sales of $5.6M Representing a 195% Quarter-Over-Quarter Increase and Over 1,600 Medical Cannabis Patients $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 10:09 AM on Monday, April 30th, 2018

Nlogo

  • Sales for the second quarter of 2018 were $5.6M,
    • representing a $3.7M or 195% increase quarter-over-quarter 
  • Gross profit for the second quarter of 2018 was $1.9M,
    • representing a $1.2M or 150% increase quarter-on-quarter
  • Over 1,600 Medical Cannabis Patients Acquired To-Date Through NamasteMD

VANCOUVER, British Columbia, April 30, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT:M5BQ), (OTCMKTS:NXTTF) is pleased to announce the filing of its unaudited quarterly financial statements, management’s discussion and analysis and certification of the quarterly filings for the second quarter of fiscal 2018. The statements for the period can be accessed on the Company’s SEDAR profile at www.sedar.com.

The Company’s sales for the second quarter of 2018 were $5.6M, representing a $3.7M or 195% increase quarter-over-quarter.  Gross profit for the second quarter of 2018 was $1.9M, representing a $1.2M or 150% increase quarter-on-quarter. For the first six months of the year, the Company had sales of $10.6M, representing a $6.6M or 165% increase year-on-year. Gross profit for the first six months of 2018 was $3.6M, representing a $2.1M or 140% increase year-over-year. The gross profit increase relates primarily to the growth in revenue outside the United States.

Namaste’s management team is extremely encouraged by the financial position of the Company and anticipates seeing accelerated growth in Q3 and Q4 of 2018. The Company has been focused on launching many new initiatives, the most significant of which is the addition of medical cannabis sales through the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”). Namaste will focus on expanding its international platform and in developing new opportunities domestically and abroad.

The Company has also seen a significant impact on Canadian operating costs for its hardware business, correlated to the integration of Namaste’s platform with Greenlane Canada Inc., whereby inventory management and order processing are fulfilled by Greenlane. The integration with Greenlane has completely removed all inventory costs and has also streamlined operations. The Company anticipates further cost reductions by pursuing similar strategic partnerships which bring long-term value to the Company and its shareholders.

Namaste’s management team is now highly focused on patient acquisition through the Company’s innovative telemedicine application, NamasteMD. To date, the company has acquired over 1,600 patients, all of which were driven organically through Namaste’s platform. The Company’s marketing team will be working through various marketing channels to further accelerate patient growth while expanding its clinic team in order to accommodate anticipated demand. With strong initial results on patient acquisition costs and conversion rates, Namaste believes that it will be able to acquire medical patients faster and at a lower cost than any of its industry peers.

The Company is also looking forward to trading on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer, which will provide Namaste and its shareholders with many advantages, including greater visibility and enhanced market access for Canadian and international investors.

Quarterly Financial Highlights

  • The majority of revenues were generated by several key markets. The top five countries generated 85% of revenues for the second quarter of 2018 compared to 84% for the second quarter of 2017. The table below depicts gross revenues by country.
Revenues by country
For three months ended For six months ended
Country February 28,
2018
February 28,
2017
February 28,
2018
February 28,
2017
United Kingdom $1,346,193.00 $737,946.00 $2,580,175.81 $1,285,227.00
Australia $1,234,429.00 $91,371.00 $2,650,200.00 $170,254.62
United States of America $1,140,217.00 $525,518.00 $1,817,768.84 $1,437,529.00
Brazil $380,879.00 $100,591.00 $735,322.92 $202,514.00
Canada $678,815.00 $78,985.00 $1,034,446.63 $159,223.00
Germany $287,878.00 $32,660.00 $550,487.86 $56,097.00
New Zealand $71,714.00 $75,149.00 $176,197.59 $209,317.00
Ireland $36,902.00 $51,759.00 $98,722.14 $87,264.00
Israel $94,160.00 $26,367.00 $157,004.13 $48,603.00
Other $362,643.00 $186,760.00 $764,614.08 $338,265.38
Total $5,633,830.00 $1,907,106.00 $10,564,940.00 $3,994,294.00
  • Operating costs for the second quarter of 2018 were $5.5M compared to $2.4M for the second quarter of 2017. The $3.1M quarter-over-quarter increase in operating costs is primarily due to non-cash charges of $1.5M, which included share-based compensation, amortization of intangible assets, and depreciation.
  • Selling expenses for the second quarter of 2018 were $1.7M compared to $0.6M for the second quarter of 2017, representing an increase of $1.1M quarter-on-quarter. The increase was due in part to an increase in advertising expenses of $0.6M and consulting expenses of $0.5M. Advertising expenses related to online search services as well as other online promotional and social media tools utilized by the Company to generate sales. These costs further represent the Company’s significant investment into search engine optimization and its ongoing customer acquisition strategy. Consulting expenses relate to compensation amounts paid to various companies and individuals for marketing, order fulfillment, customer service activities, e-commerce product development, back-office e-commerce support and sales commissions. The increase in consulting fees is primarily related to information technology in order to develop current and new revenue channels.
  • Administration expenses for the second quarter of 2018 were $3.5M compared to $1.8M for the second quarter of 2017, representing an increase of $1.7M quarter-over-quarter. The increase is primarily due to share-based compensation of $1.3M and increases in merchant fees and professional fees.
  • Other expenses for the second quarter of 2018 were $0.3M compared to approximately $nil for the second quarter of 2017, representing an increase of $0.3M quarter-over-quarter. The increase was primarily due to the amortization of intangibles of $0.2M, which relates to the amortization of the customer list from the acquisition of Australian Vaporizers.

Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “We are very pleased with the Q2 financials. The Company continues to see quarter-on-quarter growth at a rapidly accelerating rate, even after having divested our US assets. Our management team remains focused on ramping up patient acquisition through NamasteMD, and we anticipate launching medical cannabis sales through Cannmart in the near future. Namaste will continue to pursue and develop innovative technologies for the cannabis industry. This will be achieved through forming mutually beneficial partnerships and in making strategic investments that bring value to both the Company and the cannabis sector as a whole. We feel that the Company is now positioned for significant growth going forward which will be achieved by accelerating patient acquisition, adding medical cannabis sales to our platform and by implementing new technologies to an already impressive platform.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 24 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., which operates a medical cannabis “sales-only” license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors
“Sean Dollinger”
Chief Executive Officer Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
www.australianvaporizers.com.au

Northern Sphere Feature: Buckeye Mine Advancing Toward Production #FCE.tsx

Posted by AGORACOM at 12:08 PM on Friday, April 27th, 2018

 

Northern Sphere’s 28.7 million shares at .09c represents a $2.5 million market cap

The Buckeye Mine:

  • All the key pieces of equipment to enable mineral processing
  • Full assay facility
  • Fully trained mine team
  • Multiple adits
  • Water tanks
  • Evaporation pond
  • Core Logging Shelter

Processing Plan:

  • Production rate of 1000 ounces silver per day from an existing adit (10 oz per ton head grade).
  • Site prep includes rehabbing of adit, evaporation pond, stockpile area for over 20,000 tonnes.
  • Permits include explosive, full assay facility with high grade concentration.
  • Mobile equipment including 2.5 cu yard mucker, two boom jumbo, skid steer, generator, and haul trailer.

 

Northern Sphere Mining Corp has its’ sights on being the best of the high-quality juniors in the mining industry.

John Carter, Chief Executive Office

Northern Sphere Mining

905 302 3843

FEATURE: Star Navigation $SNA.ca Real-Time Flight Tracking and Monitoring Technology

Posted by AGORACOM-JC at 2:53 PM on Wednesday, April 25th, 2018

STAR-A.D.S.®

  • On-board real-time monitoring and data analysis system that provides a “virtual window into an aircraft”
  • As cost-effective air to ground communication system that automatically and securely transmits flight data and incident alerts.
  • Continuously monitors selected avionics systems on the aircraft from power-on to power-off, instantly analyzes the data, and transmits selected data and any incident alerts, via satellite to the operator.
  • Acts as an early warning system, detecting the earliest signs of potential problems
  • Performs these functions in “real-time” providing essential safety monitoring to the benefit of passengers, aircraft personnel, and ground crew
  • Applications include: Commercial Airlines, Helicopters, Business Aircraft, Assist Search and Rescue by providing last transmitted location
  • Future applications: Emergency Medical Services (airborne and ground vehicles), Land vehicles

CHECK OUT OUR RECENT INTERVIEW